Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 15, 2025

Primary Completion Date

May 5, 2025

Study Completion Date

May 5, 2025

Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG

HFrEF Polypill

"The heart failure with reduced ejection fraction (HFrEF) polypill will include 4 guideline recommended medications used to treat HFrEF patients. The dose of initiation and titration will be at the investigator's discretion.~HFrEF polypill strength 1: bisoprolol 2.5 mg + losartan 25 mg + eplerenone 25 mg + dapagliflozin 10 mg; HFrEF polypill strength 2: bisoprolol 5 mg + losartan 50 mg + eplerenone 25 mg + dapagliflozin 10 mg; HFrEF polypill strength 3: bisoprolol 10 mg + losartan 100 + eplerenone 50 mg + dapagliflozin 10 mg"

OTHER

Comparator Arm

Participants in the comparator control group will receive usual care by their healthcare providers. Providers will be encouraged to treat all participants according to international and local clinical practice guidelines.

Trial Locations (2)

10350

Colombo South Teaching Hospital, Colombo

00700

National Hospital of Sri Lanka, Colombo

All Listed Sponsors
collaborator

The George Institute

OTHER

collaborator

RemediumOne

UNKNOWN

collaborator

Centre for Chronic Disease Control, India

OTHER

lead

Washington University School of Medicine

OTHER

NCT06831864 - Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka | Biotech Hunter | Biotech Hunter